Profile
DBVT VRTX REGN VRNA ARGX ALNY
Company Name DBV Technologies S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $513.36M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.11K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Daniel Tassé Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
DBVT VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
DBVT VRTX REGN VRNA ARGX ALNY
Last Close $13.48 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $17 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.47 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -20.71 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 2768.09 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
DBVT VRTX REGN VRNA ARGX ALNY
1 Month Return -20.47 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 34.8 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 21.44 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 214.95 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 336.25 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 2645.42 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DBVT VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2890 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
DBVT VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM -238.76 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -113.11 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -295.23 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -210.58 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 97.93 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 99.34 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -10164.33 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 7.84 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 1.14 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.02 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.02 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 72.59 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -7773.73 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.04 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -7.38 36.72 20 -995.27 128.45 195.85
Price To Operating Cash Flows Ratio TTM -4.2 32.86 16.23 -126.33 145.01 162.25
Price Cash Flow Ratio TTM -4.2 32.86 16.23 -126.33 145.01 162.25
Income Statement (TTM)
DBVT VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0.01B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.11B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.11B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -5.9 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
DBVT VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.04B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.03B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $16.08B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.07B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
DBVT VRTX REGN VRNA ARGX ALNY
Net Income $-0.11B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.1B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to DBVT
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.00208 174.98
AADR AdvisorShares Dorsey Wright ADR ETF 2.03 93.275
AIIQ AI Powered International Equity ETF 0.42 24.58
Unlock